{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:17:41Z","timestamp":1792113461537,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We aimed to explore the correlation between ketamine abuse and lower urinary tract symptoms (LUTS) and epidemiology of ketamine cystitis. Questionnaire records of ketamine abusers, such as sex, age, and details of using ketamine, including consumption method, amount, duration of ketamine use, and LUTS, were obtained from two private rehabilitation centers. We analyzed these factors and established a severity forecasting module. One hundred and six ketamine abusers completed the questionnaires. LUTS showed an onset time of 24.67\u2009\u00b1\u200926.36 months among ketamine abusers. Overactive bladder symptom score, international prostate symptom score-storage, interstitial cystitis symptom index, interstitial cystitis problem index, and visual analogue scale score were 5.25\u2009\u00b1\u20094.43, 5.95\u2009\u00b1\u20095.72, 10.96\u2009\u00b1\u20096.66, 9.73\u2009\u00b1\u20095.82, and 2.55\u2009\u00b1\u20093.18, respectively. All symptom scores were positively correlated with the duration of ketamine abuse. Ketamine snorting was significantly correlated with all symptom scores compared to smoking. Hydrodistention, intravesical hyaluronic acid instillation, intravesical injection with botulinum toxin, and hyperbaric-oxygen therapy showed better effect than oral treatment. Ketamine can induce severe storage symptoms, such as frequency or nocturia depending on the duration of abuse. Ketamine snorting may cause worse LUTS than smoking. Combining ketamine and other substances may exacerbate LUTS. Intravesical therapy may lead to better outcomes than oral treatment.<\/jats:p>","DOI":"10.1038\/s41598-019-43746-x","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T06:04:37Z","timestamp":1557468277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan"],"prefix":"10.1038","volume":"9","author":[{"given":"Chiao-Ching","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Tang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Lung","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Huan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dah-Shyong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"43746_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/02791072.1980.10471430","volume":"12","author":"EF Domino","year":"1980","unstructured":"Domino, E. F. History and pharmacology of PCP and PCP-related analogs. J. Psychedelic Drugs. 12, 223\u2013237 (1980).","journal-title":"J. Psychedelic Drugs."},{"key":"43746_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","volume":"113","author":"EF Domino","year":"2010","unstructured":"Domino, E. F. Taming the ketamine tiger. 1965. Anesthesiology. 113, 678\u2013684, https:\/\/doi.org\/10.1097\/ALN.0b013e3181ed09a2 (2010).","journal-title":"Anesthesiology."},{"key":"43746_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000324063","volume":"30","author":"MR Clark","year":"2011","unstructured":"Clark, M. R. & Treisman, G. J. A behaviorist perspective. Adv Psychosom Med. 30, 8\u201321, https:\/\/doi.org\/10.1159\/000324063 (2011).","journal-title":"Adv Psychosom Med."},{"key":"43746_CR4","unstructured":"Center for Substance Abuse Research (CESAR) Ketamine. University of Maryland, College Park, http:\/\/www.cesar.umd.edu\/cesar\/drugs\/ketamine.asp (2013)."},{"key":"43746_CR5","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","volume":"97","author":"G Hocking","year":"2003","unstructured":"Hocking, G. & Cousins, M. J. Ketamine in chronic pain management: an evidence-based review. Anesth. Analg. 97, 1730\u20131739 (2003).","journal-title":"Anesth. Analg."},{"key":"43746_CR6","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/j.1464-410X.2010.10031.x","volume":"107","author":"D Wood","year":"2011","unstructured":"Wood, D. et al. Recreational ketamine: from pleasure to pain. BJU Int. 107, 1881\u20131884, https:\/\/doi.org\/10.1111\/j.1464-410X.2010.10031.x (2011).","journal-title":"BJU Int."},{"key":"43746_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000338098","volume":"89","author":"Y Lai","year":"2012","unstructured":"Lai, Y. et al. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity. Urol. Int. 89, 93\u201396, https:\/\/doi.org\/10.1159\/000338098 (2012).","journal-title":"Urol. Int."},{"issue":"oct30 1","key":"43746_CR8","doi-asserted-by":"publisher","first-page":"bcr2012007244","DOI":"10.1136\/bcr-2012-007244","volume":"2012","author":"R. Jalil","year":"2012","unstructured":"Jalil, R. & Gupta, S. Illicit ketamine and its bladder consequences: is it irreversible? BMJ Case Rep. 30, https:\/\/doi.org\/10.1136\/bcr-2012-007244 (2012).","journal-title":"Case Reports"},{"key":"43746_CR9","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","volume":"185","author":"PM Hanno","year":"2011","unstructured":"Hanno, P. M. et al. AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 185, 2162\u20132170 (2011).","journal-title":"J Urol."},{"key":"43746_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno, P. M. et al. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 193, 1545\u20131553 (2015).","journal-title":"J Urol."},{"key":"43746_CR11","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/j.1464-410X.2012.11028.x","volume":"110","author":"AR Winstock","year":"2012","unstructured":"Winstock, A. R., Mitcheson, L., Gillatt, D. A. & Cottrell, A. M. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 110, 1762\u20131766, https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11028.x (2012).","journal-title":"BJU Int."},{"key":"43746_CR12","unstructured":"Hoare, J. & Moon, D. Drug misuse declared: findings from the 2009\/10 British crime survey England and Wales. Home Office, https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/116321\/hosb1310.pdf (2010)."},{"key":"43746_CR13","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.juro.2008.11.078","volume":"181","author":"V Tyagi","year":"2009","unstructured":"Tyagi, V. et al. Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J. Urol. 181, 1932\u20131938, https:\/\/doi.org\/10.1016\/j.juro.2008.11.078 (2009).","journal-title":"J. Urol."},{"key":"43746_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bju.12412","volume":"113","author":"M Boudes","year":"2014","unstructured":"Boudes, M. & De Ridder, D. Cannabinoid receptor 1 also plays a role in healthy bladder. BJU Int. 113, 142\u2013143, https:\/\/doi.org\/10.1111\/bju.12412 (2014).","journal-title":"BJU Int."},{"key":"43746_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.neuroscience.2009.01.050","volume":"159","author":"JS Walczak","year":"2009","unstructured":"Walczak, J. S., Price, T. J. & Cervero, F. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience. 159, 1154\u20131163, https:\/\/doi.org\/10.1016\/j.neuroscience.2009.01.050 (2009).","journal-title":"Neuroscience."},{"key":"43746_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/luts.12214","volume":"10","author":"E Meng","year":"2018","unstructured":"Meng, E., Hsu, Y. C. & Chuang, Y. C. Advances in intravesical therapy for bladder pain syndrome (BPS)\/interstitial cystitis (IC). Low Urin. Tract Symptoms. 10, 3\u201311, https:\/\/doi.org\/10.1111\/luts.12214 (2018).","journal-title":"Low Urin. Tract Symptoms."},{"key":"43746_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0300060517693956","volume":"45","author":"J Zeng","year":"2017","unstructured":"Zeng, J. et al. Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. J. Int. Med. Res. 45, 792 (2017).","journal-title":"J. Int. Med. Res."},{"key":"43746_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.12688\/f1000research.14344.1","volume":"7","author":"Ronald S. Duman","year":"2018","unstructured":"Ronald, S. D. Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. F1000Res. 7, https:\/\/doi.org\/10.12688\/f1000research.14344.1 (2018).","journal-title":"F1000Research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43746-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:35:45Z","timestamp":1671251745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43746-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43746"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43746-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7240"}}